293 related articles for article (PubMed ID: 31770452)
21. Patient Reporting of Adverse Drug Reactions (ADRs): Survey of Public Awareness and Predictors of Confidence to Report.
Hariraj V; Aziz Z
Ther Innov Regul Sci; 2018 Nov; 52(6):757-763. PubMed ID: 29714567
[TBL] [Abstract][Full Text] [Related]
22. Knowledge, Attitudes, and Practices of Pharmacovigilance and ADRs Spontaneous Reporting Among Pediatricians and Pediatric Residents in Jordan.
Mukattash TL; Alwadi MW; Abu-Farha RK; Jarab AS; Al-Zubiedi SA; Alwedyan T
Curr Clin Pharmacol; 2018; 13(1):45-54. PubMed ID: 29521246
[TBL] [Abstract][Full Text] [Related]
23. Medication safety knowledge, attitude, and practice among hospital pharmacists in Lebanon.
Hallit S; Hajj A; Shuhaiber P; Iskandar K; Ramia E; Sacre H; Salameh P;
J Eval Clin Pract; 2019 Apr; 25(2):323-339. PubMed ID: 30592116
[TBL] [Abstract][Full Text] [Related]
24. Adverse drug reactions during hepatitis C treatment with direct-acting antivirals: The role of medication errors, their impact on treatment discontinuation and their preventability. New insights from the Campania Region (Italy) spontaneous reporting system.
Sessa M; Bernardi FF; Vitale A; Schiavone B; Gritti G; Mascolo A; Bertini M; Scavone C; Sportiello L; Rossi F; Capuano A
J Clin Pharm Ther; 2018 Dec; 43(6):867-876. PubMed ID: 30014479
[TBL] [Abstract][Full Text] [Related]
25. Safety of medicines-Pharmacists' knowledge, practice, and attitudes toward pharmacovigilance and adverse drug reactions reporting process.
Kopciuch D; Zaprutko T; Paczkowska A; Ratajczak P; Zielińska-Tomczak Ł; Kus K; Nowakowska E
Pharmacoepidemiol Drug Saf; 2019 Dec; 28(12):1543-1551. PubMed ID: 31148344
[TBL] [Abstract][Full Text] [Related]
26. Pediatric pharmacovigilance in an institute of national importance: Journey has just begun.
Sharma PK; Misra AK; Gupta N; Khera D; Gupta A; Khera P
Indian J Pharmacol; 2017; 49(5):390-395. PubMed ID: 29515280
[TBL] [Abstract][Full Text] [Related]
27. The value of patient reporting to the pharmacovigilance system: a systematic review.
Inácio P; Cavaco A; Airaksinen M
Br J Clin Pharmacol; 2017 Feb; 83(2):227-246. PubMed ID: 27558545
[TBL] [Abstract][Full Text] [Related]
28. Healthcare personnel's experience of reporting adverse drug reactions in Baghdad city: cross-sectional study.
Hussain SA; Abbas AN; Habeeb SA; Abd-Ali AK; Abdulrahman ZS
Int J Clin Pharm; 2019 Oct; 41(5):1307-1313. PubMed ID: 31240554
[TBL] [Abstract][Full Text] [Related]
29. Identification of discrepancies between adverse drug reactions coded by medical records technicians and those reported by the pharmacovigilance team in pediatrics: An intervention to improve identification, reporting, and coding.
Soyer J; Necsoiu D; Desjardins I; Lebel D; Bussières JF
Arch Pediatr; 2019 Oct; 26(7):400-406. PubMed ID: 31611146
[TBL] [Abstract][Full Text] [Related]
30. Reporting of adverse drug reactions in India: A review of the current scenario, obstacles and possible solutions.
Mulchandani R; Kakkar AK
Int J Risk Saf Med; 2019; 30(1):33-44. PubMed ID: 30175985
[TBL] [Abstract][Full Text] [Related]
31. Detection and Reporting of Adverse Drug Reactions Related to Antibiotics in Primary Healthcare in Greece.
Geitona M; Toska A; Latsou D; Saridi M
Curr Drug Saf; 2022; 17(3):217-224. PubMed ID: 34749626
[TBL] [Abstract][Full Text] [Related]
32. Preventable and potentially preventable serious adverse reactions induced by oral protein kinase inhibitors through a database of adverse drug reaction reports.
Egron A; Olivier-Abbal P; Gouraud A; Babai S; Combret S; Montastruc JL; Bondon-Guitton E
Target Oncol; 2015 Jun; 10(2):229-34. PubMed ID: 25056801
[TBL] [Abstract][Full Text] [Related]
33. Language does not come "in boxes": Assessing discrepancies between adverse drug reactions spontaneous reporting and MedDRA® codes in European Portuguese.
Inácio P; Airaksinen M; Cavaco A
Res Social Adm Pharm; 2015; 11(5):664-74. PubMed ID: 25596069
[TBL] [Abstract][Full Text] [Related]
34. Pharmacovigilance in healthcare education: students' knowledge, attitude and perception: a cross-sectional study in Saudi Arabia.
Alwhaibi M; Alhindi G; Alshamrani M; Essa MB; A Al Aloola N; Alhawassi TM
BMC Med Educ; 2020 Jul; 20(1):210. PubMed ID: 32616054
[TBL] [Abstract][Full Text] [Related]
35. Does spontaneous adverse drug reactions' reporting differ between different reporters? A study in Toulouse Pharmacovigilance Centre.
Nicol C; Moulis F; Bondon-Guitton E; Durrieu G; Montastruc JL; Bagheri H
Therapie; 2019 Oct; 74(5):521-525. PubMed ID: 31029402
[TBL] [Abstract][Full Text] [Related]
36. Monitoring medicines use: the role of the clinical pharmacologist.
Williams D
Br J Clin Pharmacol; 2012 Oct; 74(4):685-90. PubMed ID: 22554404
[TBL] [Abstract][Full Text] [Related]
37. Addressing the under-reporting of adverse drug reactions in public health programs controlling HIV/AIDS, Tuberculosis and Malaria: A prospective cohort study.
Avong YK; Jatau B; Gurumnaan R; Danat N; Okuma J; Usman I; Mordi D; Ukpabi B; Kayode GA; Dutt S; El-Tayeb O; Afolabi B; Ambrose I; Agbaji O; Osakwe A; Ibrahim A; Ogar C; Nosiri H; Avong EB; Adekanmbi V; Uthman O; Abimiku A; Oni YO; Mensah CO; Dakum P; Mberu KE; Ogundahunsi OAT
PLoS One; 2018; 13(8):e0200810. PubMed ID: 30133453
[TBL] [Abstract][Full Text] [Related]
38. Adverse drug reactions: trends in a tertiary care hospital.
Rehan HS; Chopra D; Sah RK; Mishra R
Curr Drug Saf; 2012 Nov; 7(5):384-8. PubMed ID: 23150923
[TBL] [Abstract][Full Text] [Related]
39. Adverse drug reactions reported to a provincial public health sector pharmacovigilance programme in South Africa.
Jones J; Swart A; Tommy E; Cohen K; Stewart A; Voget J; Blockman M
S Afr Med J; 2020 Nov; 110(12):1226-1230. PubMed ID: 33403970
[TBL] [Abstract][Full Text] [Related]
40. [Editorial: adverse drug reactions].
Taegtmeyer AB
Ther Umsch; 2015 Dec; 72(11-12):667. PubMed ID: 26654808
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
